81_FR_78387 81 FR 78172 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

81 FR 78172 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 215 (November 7, 2016)

Page Range78172-78172
FR Document2016-26772

Federal Register, Volume 81 Issue 215 (Monday, November 7, 2016)
[Federal Register Volume 81, Number 215 (Monday, November 7, 2016)]
[Notices]
[Page 78172]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-26772]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Human Tissue Models For Infectious 
Diseases (U19).
    Date: December 1-2, 2016.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The William F. Bolger Center, Stained Glass Hall, 9600 
Newbridge Drive, Potomac, MD 20854.
    Contact Person: Brenda Lange-Gustafson, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room # 3G41B National Institutes of Health/NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5047, 
[email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation 
Grant (R01).
    Date: December 16, 2016.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Chelsea D. Boyd, Scientific Review Officer, 
Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers Lane, 
MSC-9823, Rockville, MD 20852-9834, 240-669-2081, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: November 1, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-26772 Filed 11-4-16; 8:45 am]
 BILLING CODE 4140-01-P



                                                78172                       Federal Register / Vol. 81, No. 215 / Monday, November 7, 2016 / Notices

                                                supplemental test, we recommend that                    the discussions could disclose                        as amended. The grant applications and
                                                the establishment notify consignees of                  confidential trade secrets or commercial              the discussions could disclose
                                                all previously distributed blood and                    property such as patentable material,                 confidential trade secrets or commercial
                                                blood components collected during the                   and personal information concerning                   property such as patentable material,
                                                lookback period and, if blood and blood                 individuals associated with the grant                 and personal information concerning
                                                components were transfused, encourage                   applications, the disclosure of which                 individuals associated with the grant
                                                consignees to notify the recipient’s                    would constitute a clearly unwarranted                applications, the disclosure of which
                                                physician of record of a possible                       invasion of personal privacy.                         would constitute a clearly unwarranted
                                                increased risk of T. cruzi infection.                     Name of Committee: National Institute of            invasion of personal privacy.
                                                   Respondents to this information                      Allergy and Infectious Diseases Special                 Name of Committee: National Institute of
                                                collection are establishments that                      Emphasis Panel; Human Tissue Models For               Environmental Health Sciences Special
                                                manufacture Whole Blood and blood                       Infectious Diseases (U19).                            Emphasis Panel; Research Opportunities in
                                                components intended for transfusion.                      Date: December 1–2, 2016.                           Environmental Health Sciences (R21).
                                                We believe that the information                           Time: 8:00 a.m. to 5:30 p.m.                          Date: November 21, 2016.
                                                collection provisions in the guidance for                 Agenda: To review and evaluate grant                  Time: 10:00 a.m. to 12:00 p.m.
                                                establishments to notify consignees and                 applications.                                           Agenda: To review and evaluate grant
                                                                                                          Place: The William F. Bolger Center,                applications.
                                                for consignees to notify the recipient’s                Stained Glass Hall, 9600 Newbridge Drive,               Place: NIEHS/National Institutes of Health,
                                                physician of record in the guidance do                  Potomac, MD 20854.                                    Keystone Building, Room 3118, 79 T.W.
                                                not create a new burden for respondents                   Contact Person: Brenda Lange-Gustafson,             Alexander Drive, Research Triangle Park, NC
                                                and are part of usual and customary                     Ph.D., Scientific Review Officer, Scientific          27709, (Telephone Conference Call).
                                                business practices. Since the end of                    Review Program, Division of Extramural                  Contact Person: RoseAnne M. McGee,
                                                January 2007, a number of blood centers                 Activities, Room # 3G41B National Institutes          Scientific Review Officer, Scientific Review
                                                representing a large proportion of U.S.                 of Health/NIAID, 5601 Fishers Lane, MSC               Branch, Division of Extramural Research and
                                                blood collections have been testing                     9823, Bethesda, MD 20892–9823, (240) 669–             Training, Nat. Institute of Environmental
                                                                                                        5047, bgustafson@niaid.nih.gov.                       Health Sciences, P.O. Box 12233, MD EC–30,
                                                donors using a licensed assay. We                                                                             Research Triangle Park, NC 27709, (919) 541–
                                                believe these establishments have                         Name of Committee: National Institute of
                                                                                                        Allergy and Infectious Diseases Special               0752, mcgee1@niehs.nih.gov.
                                                already developed standard operating                                                                          (Catalogue of Federal Domestic Assistance
                                                                                                        Emphasis Panel; NIAID Clinical Trial
                                                procedures for notifying consignees and                 Implementation Grant (R01).                           Program Nos. 93.115, Biometry and Risk
                                                for the consignees to notify the                          Date: December 16, 2016.                            Estimation—Health Risks from
                                                recipient’s physician of record.                          Time: 1:00 p.m. to 3:00 p.m.                        Environmental Exposures; 93.142, NIEHS
                                                   The guidance also refers to previously                 Agenda: To review and evaluate grant                Hazardous Waste Worker Health and Safety
                                                approved collections of information                     applications.                                         Training; 93.143, NIEHS Superfund
                                                found in FDA regulations. The                             Place: National Institutes of Health, 5601          Hazardous Substances—Basic Research and
                                                                                                        Fishers Lane, Rockville, MD 20892,                    Education; 93.894, Resources and Manpower
                                                collections of information in 21 CFR
                                                                                                        (Telephone Conference Call).                          Development in the Environmental Health
                                                601.12 have been approved under OMB                                                                           Sciences; 93.113, Biological Response to
                                                control number 0910–0338; the                             Contact Person: Chelsea D. Boyd, Scientific
                                                                                                        Review Officer, Scientific Review Program,            Environmental Health Hazards; 93.114,
                                                collections of information in 21 CFR                                                                          Applied Toxicological Research and Testing,
                                                                                                        DEA/NIAID/NIH/DHHS, 5601 Fishers Lane,
                                                606.100, 606.121, 606.122,                              MSC–9823, Rockville, MD 20852–9834, 240–              National Institutes of Health, HHS)
                                                606.160(b)(ix), 606.170(b), 610.40, and                 669–2081, chelsea.boyd@nih.gov.                         Dated: November 1, 2016.
                                                630.6 have been approved under OMB                      (Catalogue of Federal Domestic Assistance             Michelle Trout,
                                                control number 0910–0116; the                           Program Nos. 93.855, Allergy, Immunology,             Program Analyst, Office of Federal Advisory
                                                collections of information in 21 CFR                    and Transplantation Research; 93.856,                 Committee Policy.
                                                606.171 have been approved under                        Microbiology and Infectious Diseases
                                                                                                                                                              [FR Doc. 2016–26767 Filed 11–4–16; 8:45 am]
                                                OMB control number 0910–0458.                           Research, National Institutes of Health, HHS)
                                                                                                                                                              BILLING CODE 4140–01–P
                                                  Dated: November 1, 2016.                                Dated: November 1, 2016.
                                                Leslie Kux,                                             Natasha M. Copeland,
                                                Associate Commissioner for Policy.                      Program Analyst, Office of Federal Advisory           DEPARTMENT OF HEALTH AND
                                                [FR Doc. 2016–26792 Filed 11–4–16; 8:45 am]             Committee Policy.                                     HUMAN SERVICES
                                                BILLING CODE 4164–01–P                                  [FR Doc. 2016–26772 Filed 11–4–16; 8:45 am]
                                                                                                        BILLING CODE 4140–01–P
                                                                                                                                                              National Institutes of Health

                                                DEPARTMENT OF HEALTH AND                                                                                      Center for Scientific Review; Notice of
                                                HUMAN SERVICES                                          DEPARTMENT OF HEALTH AND                              Closed Meetings
                                                                                                        HUMAN SERVICES                                          Pursuant to section 10(d) of the
                                                National Institutes of Health                                                                                 Federal Advisory Committee Act, as
                                                                                                        National Institutes of Health                         amended (5 U.S.C. App.), notice is
                                                National Institute of Allergy and
                                                                                                                                                              hereby given of the following meetings.
                                                Infectious Diseases; Notice of Closed                   National Institute of Environmental                     The meetings will be closed to the
                                                Meetings                                                Health Sciences; Notice of Closed                     public in accordance with the
                                                                                                        Meeting                                               provisions set forth in sections
                                                  Pursuant to section 10(d) of the
                                                                                                                                                              552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
sradovich on DSK3GMQ082PROD with NOTICES




                                                Federal Advisory Committee Act, as                        Pursuant to section 10(d) of the
                                                amended (5 U.S.C. App.), notice is                      Federal Advisory Committee Act, as                    as amended. The grant applications and
                                                hereby given of the following meetings.                 amended (5 U.S.C. App.), notice is                    the discussions could disclose
                                                  The meetings will be closed to the                    hereby given of the following meeting.                confidential trade secrets or commercial
                                                public in accordance with the                             The meeting will be closed to the                   property such as patentable material,
                                                provisions set forth in sections                        public in accordance with the                         and personal information concerning
                                                552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              provisions set forth in sections                      individuals associated with the grant
                                                as amended. The grant applications and                  552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,            applications, the disclosure of which


                                           VerDate Sep<11>2014   16:02 Nov 04, 2016   Jkt 241001   PO 00000   Frm 00066   Fmt 4703   Sfmt 4703   E:\FR\FM\07NON1.SGM   07NON1



Document Created: 2018-02-14 08:21:14
Document Modified: 2018-02-14 08:21:14
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesDecember 1-2, 2016.
FR Citation81 FR 78172 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR